Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cure LBSL Foundation is a non-profit organization dedicated to finding a cure for Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL), a rare genetic white matter disease. The foundation funds and coordinates research efforts, specifically focusing on gene therapy and drug repurposing strategies to address the underlying DARS2 gene mutations. By partnering with academic institutions and biotechnology companies, the foundation aims to accelerate the development of disease-modifying treatments. Their primary mission is to support affected families while driving scientific breakthroughs toward clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cure LBSL Foundation.